What Happened?
San Francisco, CA-based Nurix Therapeutics Appointed Eric Schlezinger as Chief People Officer
About the Company
Nurix Therapeutics discovers drugs that harness the body`s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach to treat a broad range of diseases. Our focus is on developing drugs to treat cancer including novel, small molecule immuno-oncology agents.
About the Person
Eric Schlezinger is Chief People Officer at Nurix Therapeutics. Previously, Eric held various senior HR leadership roles in the industry.
Info Source
News
Short Profile